[40 years of using sulfonylurea derivatives for treatment of diabetes].
The structure and effects of sulfonylurea derivatives were described. Today the second generation of sulfonylureas rather is prescribed because of its lower dosage and better peripheral activity. The non-insulin-dependent diabetes after weight reduction and failure of other oral therapy is the main indication to introduction of sulfonylurea derivates.
Sieradzki
J
J
Katedry i Kliniki Chorób Metabolicznych, Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.
D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications; D013453:Sulfonylurea Compounds / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds